Engine Biosciences Company

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery. Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
Technology: Artificial Intelligence, Biotechnology, Health Care, Machine Learning
Industry: Drug Repurposing
Headquarters: San Francisco, California, United States
Founded Date: 2014-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 11
Total Funding: 53000000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-05-26
Last Funding Type: Series A

Visit Website
contact@enginebio.com
Register and Claim Ownership